If the analysis outcomes in such superiority, bosutinib could turn into a welcome fresh frontline treatment choice for sufferers with CML for whom few treatment plans currently exist.’.. Argon enters licensing agreement with Rex Medical for UltraStream catheter Argon Medical Devices, Inc. Leondis, President of Argon Medical Devices, Inc.’ There are over 500,000 patients currently undergoing treatment in the U.S. For End-Stage Renal Disease . It’s estimated that the dialysis patient human population will continue to grow for a price exceeding 6 percent annually. The first affected individual was dosed on July 22, 2014. On 9 January, 2014, Avillion announced it had entered into a special collaborative development contract with Pfizer Inc.BioLife Solutions, HemaCare enter strategic partnership BioLife Solutions, Inc. HypoThermosol has demonstrated amazing ability to lengthen the shelf life of the precious cell type out to 4 times, eliminating the cryopreservation procedure and its own related yield reduction, and enabling an internationally delivery footprint for new apheresis-derived cells. Mike Rice, BioLife Solutions CEO and President, commented on the announcement by stating, HemaCare gives best-in-class bioresearch products produced from the most robust and finest quality apheresis selections.